04:13 AM EDT, 05/09/2025 (MT Newswires) -- Pacira Biosciences ( PCRX ) reported Q1 non-GAAP earnings late Thursday of $0.62 per diluted share, unchanged from a year earlier.

Analysts polled by FactSet expected $0.60.

Revenue for the quarter ended March 31 was $168.9 million compared with $167.1 million a year earlier.

Analysts surveyed by FactSet expected $176 million.

The company reiterated its 2025 revenue guidance of $725 million to $765 million. Analysts surveyed by FactSet expect $749.9 million.

Pacira shares were down 7.6% in recent premarket activity Friday.